Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.24%83.070.9%$974.14m
KITEKite Pharma, Inc.
0.05%179.3916.1%$742.45m
CELGCelgene Corporation
0.52%144.641.1%$500.32m
AMGNAmgen Inc.
0.28%186.281.1%$484.51m
BIIBBiogen Inc.
-0.10%318.141.2%$421.93m
REGNRegeneron Pharmaceuticals, Inc.
1.44%438.962.7%$359.45m
ALNYAlnylam Pharmaceuticals, Inc
1.99%116.0610.7%$250.60m
ALXNAlexion Pharmaceuticals, Inc.
0.36%143.341.9%$229.81m
JUNOJuno Therapeutics, Inc.
-4.85%42.9514.6%$225.26m
VRTXVertex Pharmaceuticals Incorporated
-1.05%149.671.9%$209.15m
INCYIncyte Corporation
-1.18%109.542.6%$205.20m
ILMNIllumina, Inc.
-0.54%200.333.5%$158.56m
BLUEBluebird Bio, Inc.
1.24%130.3519.3%$143.20m
BMRNBioMarin Pharmaceutical Inc.
-0.52%94.464.4%$136.68m
CLVSClovis Oncology, Inc.
-3.04%76.1718.0%$132.29m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.